Bellus Health Stock News

Healthcare > Biotechnology

Buy BLU

*Your capital is at risk

$14.74

+0 (+0%)

At Close: Sep 27, 2023

Why Bellus Health Stock Tanked 69.2% Today

07:26pm, Monday, 06'th Jul 2020

Shares of Bellus Health (NASDAQ: BLU) (TSX: BLU) were falling 69.2% at 2:40 p.m. EST on Monday following its announcement that a phase 2 trial of BLU-5937 as a treatment for refractory chronic cough h

BELLUS Health Announces Topline Results from its Phase 2 RELIEF Trial of BLU-5937 for the Treatment of Refractory Chronic Cough

11:00am, Monday, 06'th Jul 2020

BELLUS Health Inc. (Nasdaq: BLU; TSX: BLU) ("BELLUS Health" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hyp

Hedge Funds Are Selling BELLUS Health Inc. (BLU)

01:28am, Sunday, 28'th Jun 2020

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Ev

Perspecta and Ellington Residential See Activist Actions

09:24pm, Friday, 19'th Jun 2020

Jana Partners disclosed a stake in government information-technology services firm Perspecta. Blackstone Group bought more shares of REIT Ellington.

Insider Buying: The BELLUS Health Inc. (TSE:BLU) Independent Director Just Bought 26% More Shares

12:14pm, Thursday, 18'th Jun 2020

Even if it's not a huge purchase, we think it was good to see that Clarissa Desjardins, the Independent Director of...

Penny Stocks to Buy Using Technical Analysis for June 2020

04:14pm, Friday, 29'th May 2020

These low-priced stocks may prove exempt from a potential downtrend based on their bullish technical signals.

BELLUS Health to Participate in Fireside Chat at the Jefferies Virtual Healthcare Conference

11:00am, Thursday, 28'th May 2020

The BELLUS Health (TSE:BLU) Share Price Has Soared 881%, Delighting Many Shareholders

11:25am, Friday, 22'nd May 2020

For us, stock picking is in large part the hunt for the truly magnificent stocks. You won't get it right every time...

Bellus Health (BLU) Reports Q1 Loss, Lags Revenue Estimates

10:55pm, Thursday, 14'th May 2020

Bellus (BLU) delivered earnings and revenue surprises of 0.00% and -60.00%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?